Antimicrobial and Anticancer Activities of Graphene Oxide: Mechanistic Insights into Structure–Activity Relationships, Nano–Bio Interactions, and Translational Biomedical Applications
This paper reviews the antimicrobial and anticancer activities of graphene oxide, exploring its structure–activity relationships, nano–bio interactions, and potential as a multifunctional nanoplatform to overcome the limitations of conventional therapies.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the microscopic world of modern medicine, scientists are constantly searching for materials that can fight disease without relying on the same old chemical tricks that bacteria and cancer cells have learned to defeat. For decades, the standard approach has been to design drugs that target a specific enzyme or pathway inside a cell, much like a key fitting into a single lock. However, life is adaptable; bacteria evolve to change their locks, and cancer cells find ways to ignore the key. This has led researchers to look toward the very structure of matter itself, specifically at the nanoscale, where materials behave differently than they do in bulk. One such material is graphene oxide, a substance derived from graphite, the same material found in pencil lead. Unlike the smooth, water-repelling sheets of pure graphene, graphene oxide is covered in tiny chemical groups that make it water-friendly and chemically active. These groups, along with the material's unique flat, sheet-like shape, allow it to interact with living cells in ways that are not based on a single chemical target, but rather on physical contact and the generation of stress within the cell.
A team of researchers from universities in Gujarat, India, set out to understand exactly how this material works against two of humanity's most persistent enemies: drug-resistant bacteria and aggressive cancer. They synthesized graphene oxide in their lab and carefully examined its physical structure before testing it on living cells. They wanted to see if the material's shape and chemical makeup could explain why it kills some cells more easily than others. Their work focused on four types of bacteria—two with simple outer walls and two with complex, protective armor—and three types of human cancer cells, including lung cancer and two distinct forms of breast cancer. By watching how these cells reacted to the material over time, the researchers mapped out a clear picture of how a simple sheet of carbon can become a powerful tool against disease.
The study began by creating a stable suspension of graphene oxide, ensuring the material was evenly spread out in liquid so it could interact freely with the test subjects. The researchers first turned their attention to bacteria, testing the material against Staphylococcus aureus and Enterococcus faecalis, which have relatively simple cell walls, and Escherichia coli and Pseudomonas aeruginosa, which possess a tougher, double-layered outer membrane. When they placed the graphene oxide near these bacteria, they observed that the material successfully stopped the growth of all four types. However, the ease with which it worked varied significantly. The bacteria with the simpler walls were much more vulnerable, showing large clear zones where no bacteria could grow. The bacteria with the complex outer armor were still affected, but the material had to work harder to penetrate their defenses. This difference highlighted a crucial point: the material does not rely on a chemical key to unlock the cell; instead, it acts like a physical barrier and a source of stress that the cell cannot easily evade.
The researchers identified four main ways the graphene oxide attacks bacteria. First, the edges of the graphene sheets are incredibly sharp at the atomic level. When these sheets touch a bacterial cell, the sharp edges can physically cut or puncture the cell membrane, much like a microscopic blade. Second, the material generates reactive oxygen species, which are highly unstable molecules that damage the cell's internal components, including its DNA and proteins. Third, the graphene sheets can pull essential fats, known as phospholipids, directly out of the bacterial membrane, causing the wall to fall apart. Finally, the flexible sheets can wrap around the bacteria, trapping them and cutting off their access to nutrients and oxygen. Because the bacteria face all these attacks at once, it is much harder for them to develop resistance compared to facing a single antibiotic.
The investigation then moved to human cancer cells, where the researchers tested the material on lung cancer cells and two types of breast cancer cells: one that is hormone-sensitive and another that is triple-negative, a more aggressive form that lacks the usual targets for standard therapies. The results showed that the graphene oxide was toxic to all three cancer types, but the level of sensitivity depended heavily on the specific genetic makeup of the cells. The triple-negative breast cancer cells were the most vulnerable, with their growth significantly slowed down at much lower concentrations of the material. In contrast, the hormone-sensitive breast cancer cells were far more resistant, requiring much higher doses to see the same effect. The lung cancer cells fell somewhere in the middle.
This difference in sensitivity was linked to the internal machinery of the cells. The more resistant cells possessed a functional protein that helps them repair damage and pause their growth cycle to fix errors. When the graphene oxide caused stress, these cells could temporarily stop and repair themselves. The triple-negative cells, however, lacked this repair mechanism. When the graphene oxide damaged them, they could not pause to fix the injury, leading to a rapid collapse and cell death. The researchers observed this process under a microscope, watching the cells shrink, lose their shape, and detach from their surface as they died. The material caused the cells to lose their structural integrity and stop functioning, confirming that the physical and chemical stress induced by the graphene oxide was the primary driver of cell death.
The study concludes that the power of graphene oxide lies not in a single chemical reaction, but in a combination of its physical shape, its sharp edges, and its ability to create internal stress. It acts as a multi-tool that attacks cells through mechanical damage, chemical oxidation, and physical entrapment. While the material showed promise in the lab, the researchers noted that these findings are based on controlled experiments with isolated cells and bacteria. Translating this into a treatment for people will require further study to ensure the material is safe for the whole body and to understand how it behaves in a complex living system. Nevertheless, the work provides a clear roadmap for how the structure of a material dictates its biological effect, suggesting that by tuning the physical properties of graphene oxide, scientists might be able to create new, highly effective treatments for infections and cancer that bypass the resistance mechanisms that have made current drugs less effective.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.